FutureX Capital Limited - Net Worth and Insider Trading

FutureX Capital Limited Net Worth

The estimated net worth of FutureX Capital Limited is at least $56 Million dollars as of 2024-12-11. FutureX Capital Limited is the of Cryofocus Medtech (Shanghai) Co Ltd and owns about 7,963,128 shares of Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) stock worth over $56 Million. Details can be seen in FutureX Capital Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that FutureX Capital Limited has not made any transactions after 2022-12-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of FutureX Capital Limited

FutureX Capital Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, FutureX Capital Limited owns 1 companies in total, including Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) .

Click here to see the complete history of FutureX Capital Limited’s form 4 insider trades.

Insider Ownership Summary of FutureX Capital Limited

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:06922	Cryofocus Medtech (Shanghai) Co Ltd	2022-12-30

FutureX Capital Limited Latest Holdings Summary

FutureX Capital Limited currently owns a total of 1 stock. FutureX Capital Limited owns 7,963,128 shares of Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) as of December 30, 2022, with a value of $56 Million.

Latest Holdings of FutureX Capital Limited

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:06922	Cryofocus Medtech (Shanghai) Co Ltd	2022-12-30	7,963,128	6.99	55,662,265

Holding Weightings of FutureX Capital Limited

FutureX Capital Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, FutureX Capital Limited has made a total of 1 transactions in Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Cryofocus Medtech (Shanghai) Co Ltd is the sale of 0 shares on December 30, 2022, which brought FutureX Capital Limited around $0.

Insider Trading History of FutureX Capital Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

FutureX Capital Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

FutureX Capital Limited Ownership Network

Ownership Network List of FutureX Capital Limited

No Data

Ownership Network Relation of FutureX Capital Limited

FutureX Capital Limited Owned Company Details

What does Cryofocus Medtech (Shanghai) Co Ltd do?

Who are the key executives at Cryofocus Medtech (Shanghai) Co Ltd?

FutureX Capital Limited is the of Cryofocus Medtech (Shanghai) Co Ltd. Other key executives at Cryofocus Medtech (Shanghai) Co Ltd include 2101 Beneficial owner Wu Jianhui , 2202 Interest of your spouse Li Hui , and 2103 Interests held jointly with another person Lv Shiwen .

Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) Insider Trades Summary

Over the past 18 months, FutureX Capital Limited made no insider transaction in Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922). Other recent insider transactions involving Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) include a net sale of 0 shares made by Li Hui , a net purchase of 2,419,000 shares made by Wu Jianhui , and a net sale of 0 shares made by Lv Shiwen .

In summary, during the past 3 months, insiders sold 0 shares of Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) were sold and 2,419,000 shares were bought by its insiders, resulting in a net purchase of 2,419,000 shares.

Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cryofocus Medtech (Shanghai) Co Ltd Insider Transactions

No Available Data

FutureX Capital Limited Mailing Address

Above is the net worth, insider trading, and ownership report for FutureX Capital Limited. Currently GuruFocus does not have mailing address information for FutureX Capital Limited.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.